Stage IV Melanoma Mastic NY

Patients with stage IV, or metastatic, melanoma have cancer that has spread from its site of origin to distant lymph nodes and/or distant sites. Additional prognostic factors for stage IV melanoma include site of distant metastases and elevated blood enzyme LDH levels. Distant lymph node metastases and lung metastases have a better prognosis than other distant metastases, such as the brain or liver.

Yat Hong Lau, MD
(631) 444-2210
Brookhaven Natl Lab Medicine Rsrch Center Building
Upton, NY
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Male
Education
Medical School: Suny-Hlth Sci Ctr At Syracuse, Coll Of Med, Syracuse Ny 13210
Graduation Year: 1987

Data Provided by:
Jiyeon Kim, MD
(631) 758-7575
285 Sills Rd Bldg 16
East Patchogue, NY
Specialties
Oncology (Cancer)
Gender
Female
Education
Medical School: Va Commonwealth Univ, Med Coll Of Va Sch Of Med, Richmond Va 23298
Graduation Year: 1991

Data Provided by:
Russell Scott Berman, MD
(516) 289-0300
260 Patchogue Yaphank Rd
East Patchogue, NY
Specialties
Oncology (Cancer), General Surgery
Gender
Male
Education
Medical School: New York Univ Sch Of Med, New York Ny 10016
Graduation Year: 1990
Hospital
Hospital: Bellevue Hosp Center, New York, Ny; New York Univ Med Ctr/Tisch, New York, Ny
Group Practice: New York Univ Medical Ctr

Data Provided by:
John Joseph Butler Jr, MD
1504 Yarrow Cir
Bellport, NY
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Univ Of Rochester Sch Of Med & Dentistry, Rochester Ny 14642
Graduation Year: 1944

Data Provided by:
Anjali Sharma, MD
(732) 915-7789
208A Beaumont Pl
Coram, NY
Specialties
Oncology (Cancer)
Gender
Female
Education
Medical School: Lady Hardinge Med Coll, Univ Of Delhi, New Delhi, Delhi, India
Graduation Year: 1996

Data Provided by:
Mohammed Saha-adat Hossain
(631) 475-1684
130 Hospital Rd
East Patchogue, NY
Specialty
Hematology / Oncology

Data Provided by:
Sheryl Green, MD
(631) 475-8846
285 Sills Rd
East Patchogue, NY
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Female
Education
Medical School: Univ Of The Witwatersrand, Med Sch, Johannesburg, So Africa
Graduation Year: 1987

Data Provided by:
Vijay Shah
(718) 204-0414
444 W Main St
Patchogue, NY
Specialty
Hematology / Oncology

Data Provided by:
Rana Zoeb, MD
74 Southaven Ave Ste C
Medford, NY
Specialties
Oncology (Cancer)
Gender
Female
Education
Medical School: Indira Ghandi Med Coll, Nagpur Univ, Nagpur, Maharashtra, India
Graduation Year: 1982

Data Provided by:
Robert Steven Festa, MD
(516) 588-4464
270 Union Ave
Holbrook, NY
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Suny-Hlth Sci Ctr At Brooklyn, Coll Of Med, Brooklyn Ny 11203
Graduation Year: 1972

Data Provided by:
Data Provided by:

Stage IV Melanoma

Provided By: 

Overview

Patients with stage IV, or metastatic, melanoma have cancer that has spread from its site of origin to distant lymph nodes and/or distant sites. Additional prognostic factors for stage IV melanoma include site of distant metastases and elevated blood enzyme LDH levels. Distant lymph node metastases and lung metastases have a better prognosis than other distant metastases, such as the brain or liver.

A variety of factors ultimately influence a patient’s decision to receive treatment of cancer. The purpose of receiving cancer treatment may be to improve symptoms through local control of the cancer, increase a patient’s chance of cure, or prolong a patient’s survival. The potential benefits of receiving cancer treatment must be carefully balanced with the potential risks of receiving cancer treatment.

The following is a general overview of the treatment of stage IV melanoma. Circumstances unique to your situation and prognostic factors of your cancer may ultimately influence how these general treatment principles are applied. The information on this Web site is intended to help educate you about your treatment options and to facilitate a mutual or shared decision-making process with your treating cancer physician.

Most new treatments are developed in clinical trials. Clinical trials are studies that evaluate the effectiveness of new drugs or treatment strategies. The development of more effective cancer treatments requires that new and innovative therapies be evaluated with cancer patients. Participation in a clinical trial may offer access to better treatments and advance the existing knowledge about treatment of this cancer. Clinical trials are available for most stages of cancer. Patients who are interested in participating in a clinical trial should discuss the risks and benefits of clinical trials with their physician. To ensure that you are receiving the optimal treatment of your cancer, it is important to stay informed and follow the cancer news in order to learn about new treatments and the results of clinical trials.

Patients with stage IV melanoma cannot be cured with surgery alone and appear to benefit modestly with currently approved systemic therapies. There are many choices of therapy for patients with stage IV melanoma; however, the majority of patients still experience cancer progression. Clinical responses are observed in 5-10% of patients with stage IV melanoma, irrespective of the mode of treatment. These responses and the fact that some are long lasting, have generated optimism about the treatment of stage IV melanoma.

Treatment strategies that are part of both curative and palliative approaches include single agent and combination chemotherapy; biological therapy with interferons; interleukins; vaccines; combination therapy; external beam radiation; isolated limb perfusion techniques and surgery. Chemotherapy combined with biologic agents offers the promise of higher response rates and...

Click here to read more from CancerConnect.com